3 research outputs found
What To Expect from Conducting Polymers on the Playground of Thermoelectricity: Lessons Learned from Four High-Mobility Polymeric Semiconductors
Modification
of the electronic structures of two benchmark donor–acceptor
(D–A) copolymers polyÂ[(4,4′-bisÂ(2-ethylhexyl)ÂdithienoÂ[3,2-<i>b</i>:2′,3′-<i>d</i>]Âsilole)-2,6-diyl-<i>alt</i>-(2,1,3-benzothiadiazole)-4,7-diyl] (PSBTBT) and polyÂ[{2,5-bisÂ(2-hexyldecyl)-2,3,5,6-tetrahydro-3,6-dioxopyrroloÂ[3,4-<i>c</i>]Âpyrrole-1,4-diyl}-<i>alt</i>-{[2,2′:5′,2″-terthiophene]-5,5″-diyl}]
(PDPP3T) by chemical doping is reported. Simply by dipping polymer
films into dopant solution, high electrical conductivity is achieved
and thermoelectric property of the films is optimized. Despite their
deep HOMO levels, optical absorption extending continuously to 2000
nm is observed in PSBTBT, and a high power factor around 25 ÎĽW
m<sup>–1</sup> K<sup>–2</sup> is obtained in PDPP3T.
Furthermore, temperature-dependent measurement of electrical conductivity
and Seebeck coefficients is carried out to understand transport mechanisms
and energetic distribution of carrier density of states (DOS). In
parallel, doping treatment and corresponding characterizations are
performed on donor polymers polyÂ(3-hexylthiophene) (P3HT) and polyÂ(2,5-bisÂ(3-dodecylthiophen-2-yl)ÂthienoÂ[3,2-<i>b</i>]Âthiophene) (PBTTT-C12) for comparison. Ultimately, based
on comprehensive characterizations and comparisons of the four polymers
in terms of bulk mobility, DOS, film microstructures, and molecular
structures, etc., a primitive correlation between solution-processable
polymeric semiconductors and thermoelectric properties of their doped
products is established
DataSheet_1_Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell.zip
BackgroundCuproptosis, a novel mode of cell death associated with the tricarboxylic acid (TCA) cycle, is relevant to the development of cancer. However, the impact of single-cell-based Cuproptosis-associated lncRNAs on the Tumor immune microenvironment (TIME) of Pancreatic adenocarcinoma (PAAD) and its potential value for individualized immunotherapy has not been clarified.Methods14 immune-related CRGs were screened by exploring the interaction between differentially expressed Immune-Related Genes (IRGs) and Cuproptosis-Related Genes (CRGs) in PAAD. Next, the expression amount and expression distribution of CRGs in single-cell samples were analyzed by focusing on 7-CRGs with significant expressions. On the one hand, MAP2K2, SOD1, and VEGFA, which were significantly differentially expressed between PAAD sites and normal tissues adjacent to them, were subjected to immunohistochemical validation and immune landscape analysis. On the other hand, from these 7-CRGs, prognostic signatures of lncRNAs were established by co-expression and LASSO-COX regression analysis, and their prognostic value and immune relevance were assessed. In addition, this study not only validated the hub CRGs and the lncRNAs constituting the signature in a PAAD animal model treated with immunotherapy-based combination therapy using immunohistochemistry and qRT-PCR but also explored the potential value of the combination of targeted, chemotherapy and immunotherapy.ResultsBased on the screening of 7-CRGs significantly expressed in a PAAD single-cell cohort and their co-expressed Cuproptosis-Related lncRNAs (CRIs), this study constructed a prognostic signature of 4-CRIs named CIR-score. A Nomogram integrating the CIR-score and clinical risk factors was constructed on this basis to predict the individualized survival of patients. Moreover, high and low-risk groups classified according to the median of signatures exhibited significant differences in clinical prognosis, immune landscape, bioenrichment, tumor burden, and drug sensitivity. And the immunohistochemical and qRT-PCR results of different mouse PAAD treatment strategies were consistent with the trend of inter-group variability in drug sensitivity of hub CRGs and CIR-score. The combination of immunotherapy, targeted therapy, and chemotherapy exhibited a better tumor suppression effect.ConclusionCIR-score, as a Cuproptosis-related TIME-specific prognostic signature based on PAAD single cells, not only predicts the prognosis and immune landscape of PAAD patients but also provides a new strategy for individualized immunotherapy-based combination therapy.</p
DataSheet_1_Construction and validation of a RARRES3-based prognostic signature related to the specific immune microenvironment of pancreatic cancer.zip
BackgroundTumor immune microenvironment (TiME) is prognostically instructive in Pancreatic adenocarcinoma (PAAD). However, the potential value of TiME-related genes in the individualized immunotherapy of PAAD has not been clarified.MethodsCorrelation between Immune-Related Genes (IRGs) and immune-related transcription factors (TFs) was performed to prove the immune correlation of selected genes. Immune-related molecular subtypes were identified by consensus clustering. The TiME-score, an immune microenvironment-related prognostic signature for PAAD, was constructed using minimum absolute contraction and selection operator regression (Lasso-Cox). The International Cancer Genome Consortium (ICGC) dataset validated the reliability of TiME-score as external validation. Single-cell samples from GSE197177 confirmed microenvironment differences of TiME-score hub genes between tumor and its paracancer tissues. Then, RARRES3, a hub gene in TiME-score, was further analyzed about its upstream TP53 mutation and the specific immune landscape of itself in transcriptome and Single-cell level. Eventually, TiME-score were validated in different therapeutic cohorts of PAAD mice models.ResultsA 14-genes PAAD immune-related risk signature, TiME-score, was constructed based on IRGs. The differences of TiME-score hub genes in single-cell samples of PAAD cancer tissues and adjacent tissues were consistent with the transcriptome. Single-cell samples of cancer tissues showed more pronounced immune cell infiltration. The upstream mutation factor TP53 of RARRES3 was significantly enriched in immune-related biological processes. High RARRES3 expression was correlated with a worse prognosis and high macrophages M1 infiltration. Additionally, the immunohistochemistry of hub genes AGT, DEFB1, GH1, IL20RB, and TRAF3 in different treatment cohorts of mice PAAD models were consistent with the predicted results. The combination of immunotherapy, chemotherapy and targeted therapy has shown significantly better therapeutic effects than single drug therapy in PAAD.ConclusionTiME-score, as a prognostic signature related to PAAD-specific immune microenvironment constructed based on RARRES3, has predictive value for prognosis and the potential to guide individualized immunotherapy for PAAD patients.</p